The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.
Coagulation Factor IX, Human, recombinant
ATC (Anatomical Therapeutic Chemical Classification)
Blood coagulation factor substitute
- Factor IX coagulationis humanus (ADNr) (Latin)
- Blutgerinnungsfaktor IX vom Menschen, rekombinant (German)
- Facteur de coagulation humain, recombinant (French)
Baxter, Spain; Baxter, Ireland; Biovitrum, Sweden; Pfizer, Switzerland; Wyeth, Austria; Wyeth, Australia; Wyeth, Belgium; Wyeth, Brazil; Wyeth, Canada; Wyeth, Chile; Wyeth, Colombia; Wyeth, Czech Republic; Wyeth, Germany; Wyeth, Denmark; Wyeth, Finland; Wyeth, France; Wyeth, Greece; Wyeth, Hungary; Wyeth, Iceland; Wyeth, Italy; Wyeth, Luxembourg; Wyeth, Netherlands; Wyeth, New Zealand; Wyeth, Sweden; Wyeth, Taiwan; Wyeth, United States; Wyeth, Venezuela; Wyeth Europa, Norway; Wyeth Pharmaceuticals, United Kingdom
Swedish Orphan, Germany
|BAN||British Approved Name|
|JAN||Japanese Accepted Name|
|USAN||United States Adopted Name|
Click for further information on drug naming conventions and International Nonproprietary Names.